The Long Run with Luke Timmerman
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
September 9, 2026·1h 36m
Episode Description from the Publisher
Mathai Mammen, CEO of Cambridge, Mass.-based Parabilis Medicine, on developing alpha helical peptide molecules against hard targets of disease.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Long Run with Luke Timmerman
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
August 25, 2026·1h 7m
Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases
August 11, 2026·1h 17m
Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases
July 28, 2026·1h 7m
Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
July 14, 2026·1h 8m
Get summaries like this every morning.
Free AI-powered recaps of The Long Run with Luke Timmerman and your other favorite podcasts, delivered to your inbox.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.